Ask AI

Downloadable Slides

Share

Program Content

Activities

  • Targeting TROP2 and TIGIT in lung cancer
    Targeting TROP-2 and TIGIT: Experts Discuss How ADCs and Immunotherapeutic Combinations Are Transforming Lung Cancer Treatment
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 28, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.